Just for the record, we no longer own CardioCel and a big group I.e LeMaitre did their due diligence and bought it from us for a good price. There were some early issues around the use of patches on high pressure grafts and that’s why the 3D aortic arch was developed.
https://marketexclusive.com/lemaitre-vascular-inc-nasdaqlmat-files-an-8-k-entry-into-a-material-definitive-agreement-2/2019/10/
Just for the record, we no longer own CardioCel and a big group...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.30 |
Change
0.300(1.67%) |
Mkt cap ! $351.7M | |||
| Open | High | Low | Value | Volume |
| $18.25 | $18.30 | $18.01 | $12.33K | 679 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $18.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.30 | 247 | 2 |
View Market Depth
| Last trade - 14.56pm 04/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |